среда, 21 декабря 2016 г.

Sanofi talks with Actelion progressing - source

Sanofi talks with Actelion progressing - source


Dec 20 Talks between Actelion and Sanofi are making progress, despite investors' anxiety as to whether the Swiss biotech firm's chief executive really wants a deal, a person with direct knowledge of situation said on Tuesday. The source said Actelion had now reached a point where the company needed to sign a deal and it could not call off negotiations with the French drugmaker without triggering an investor rebellion demanding the overthrow of its board.



from Biotech News